Home FOR AUTHORS General Physiology and Biophysics 2022 General Physiology and Biophysics Vol.41, No.1, p. 31–42, 2022

Journal info


Quarterly, 80 pp. per issue
Founded: 1982
ISSN  1338-4325 (online)

Published in English

Aims and Scope
Editorial Info
Abstracting and Indexing
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

General Physiology and Biophysics Vol.41, No.1, p. 31–42, 2022

Title: Roles of NOD1/Rip2 signal pathway in carotid artery remodelling in spontaneous hypertensive rats
Author: Jingsi Zhang, Bingqian Fang, Lingmin Sun, Xiuzhen Zhang, Jinli Liu, Yun Yang, Wenhua Zhang, Xiuli Wang, Yanchun Ding
Abstract: Nucleotide-binding and oligomerization domain (NOD) receptor is a member of inherent immunity recognition receptor family. We investigated the NOD1/Rip2 signalling pathway on carotid arterial remodelling in spontaneously hypertensive rats (SHRs). SHRs were treated with NOD1 agonist (iE-DAP), inhibitor (ML130), or normal saline. We determined the NOD1 and Rip2 expression in carotid artery tissues, serum tumour necrosis factor-α (TNF-α) and monocyte chemotactic protein-1 (MCP-1). The carotid artery remodelling in 16-week SHRs was higher than that of 8-week SHRs and 16-week Wistar-Kyoto (WKY) rats. Expression of NOD1, Rip2, MCP-1 and TNF-α in 16-week SHRs was higher than that of 8-week SHRs and 16-week WKY rats. Blood pressure in iE-DAP-treated SHRs was higher than SHR-C group (no treatment), together with MCP-1, TNF-α, NOD1 and Rip2 expression, as well as carotid artery remodelling. In ML130-treated group, these aspects were completely the opposite. Taken together, inhibition of NOD1/Rip2 signalling pathway could delay the vascular remodelling process.
Keywords: Hypertension — Carotid artery remodelling — NOD1/Rip2 signal pathway — Inflammation — Blood pressure
Published online: 14-Feb-2022
Year: 2022, Volume: 41, Issue: 1 Page From: 31, Page To: 42
doi:10.4149/gpb_2021042


download file


© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.